942
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma

, &
Pages 1300-1306 | Accepted 21 Aug 2013, Published online: 19 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ravi K. Goyal, Gebra Cuyun Carter, Saurabh P. Nagar, Emily Nash Smyth, Gregory L. Price, Rohan C. Parikh, Yu-Jing Huang, Li Li, Keith L. Davis & James A. Kaye. (2021) Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2– metastatic breast cancer in the United States. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 699-710.
Read now
Ravi K. Goyal, Gebra Cuyun Carter, Saurabh P. Nagar, Emily N. Smyth, Gregory L. Price, Yu-Jing Huang, Li Li, Keith L. Davis & James A. Kaye. (2019) Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer. Current Medical Research and Opinion 35:10, pages 1699-1710.
Read now
Nessn H. Azawi, Simon Moeller Joergensen, Niels Viggo Jensen, Peter E. Clark & Lars Lund. (2016) Trends in kidney cancer among the elderly in Denmark, 1980–2012. Acta Oncologica 55:sup1, pages 79-84.
Read now
Rohit Borker. (2014) Costs associated with adverse events in patients with metastatic renal cell carcinoma. Journal of Medical Economics 17:11, pages 792-797.
Read now

Articles from other publishers (2)

Chun-Ru Chien, Daniel M. Geynisman, Bumyang Kim, Ying Xu & Ya-Chen Tina Shih. (2018) Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review. PharmacoEconomics 37:3, pages 301-331.
Crossref
Esther A. Kleibeuker, Matthijs A. ten Hooven, Henk M. Verheul, Ben J. Slotman & Victor L. Thijssen. (2015) Combining radiotherapy with sunitinib: lessons (to be) learned. Angiogenesis 18:4, pages 385-395.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.